The nucleoprotein (NP) of Marburg virus (MBG), a filovirus, is encoded by the gene closest to the 3' end of the non-segmented negative-strand RNA genome. Sequence comparison has indicated that NP is the functional equivalent to the nucleoproteins of paramyxoviruses and rhabdoviruses. Expression of recombinant NP in two eukaryotic systems using vaccinia virus and baculovirus (vectors pSCll and pAcYMB1, respectively) and analysis of MBG-specific proteins have demonstrated that the NP of MBG is phosphorylated. The NP appeared in two forms differing in M r by about 2K (94K and 92K respectively) . Dephosphorylation clearly demonstrated that the 94K form is phosphorylated whereas the 92K form is unphosphorylated. In virion particles NP was exclusively present in the phosphorylated form. These findings suggest that only the phosphorylated NP can form nucleocapsid complexes and interact with the genomic RNA.
Introduction
The family Filoviridae accommodates Marburg virus (MBG), the prototype of the family, Ebola virus (EBO) and Reston virus (RES) (Kiley et al., 1982; Murphy et al., 1990) . Filoviruses are classified in the order Mononegavirales (Pringle, 199l) which also contains the nonsegmented negative-strand (NNS) RNA virus families Paramyxoviridae and Rhabdoviridae. MBG and EBO are extremely pathogenic for humans and non-human primates, causing a severe haemorrhagic disease with high mortality rates.
MBG particles consist of at least seven structural proteins: the L protein (Mtihlberger et al., 1992) , the glycoprotein (GP) , the nucleoprotein (NP) (94K) , and four viral structural proteins (VP) with MrS of 38K (VP40), 32K (VP35), 28K (VP30) and 24K (VP24) (Kiley et al., 1988) . The corresponding genes are located on the NNS RNA genome in the following linear order: 3' untranslated region-NP-VP35-VP40-GP-VP30-VP24-L 5' untranslated region .
The mature NP in MBG particles has an M r of 94K and is the major component of the viral nucleocapsid. It represents approximately 27 % of the virion protein mass (Kiley et al., 1988) . The nucleic acid sequence of the NP gene has been recently elucidated . t Present address: Special Pathogens Branch, Centers for Disease Control, 1600 Clifton Road, Mail Stop G14. Atlanta, Georgia 30333, U.S.A.
Comparison of the deduced amino acid sequence showed a high degree of homology to the N-terminal 400 amino acids of the EBO NP. A small region in the middle of the NP sequence was found to contain a significant homology with the nucleoproteins of paramyxoviruses and to a lesser extent with those of rhabdoviruses (Barr et al., 1991; .
Little is known about the mode of transcription and replication of filoviruses and their unusually high pathogenicity. Detailed knowledge of the functions of the various MBG proteins, their co-and posttranslational modifications, and their interactions with virion or cellular proteins or nucleic acids would create a foundation for further investigations. Studies on paramyxoviruses and rhabdoviruses have shown that the nucteoprotein plays an important role in the transcription and replication of these viruses. The nucleoprotein encapsidates the template RNA which is the only form that is transcribed. Newly synthesized nucleoprotein seems to mediate the formation of plus-sense ribonucleoprotein complexes which are the template for synthesis of progeny minus-sense RNA (for reviews see Wagner, 1987; Kingsbury, 1991; Banerjee & Barik, 1992) . In this report we present data on the expression of MBG NP in eukaryotic and prokaryotic systems and show that the mature NP is phosphorylated. Propagation and labelling of virus. E6 cells were infected with MBG at an m.o.i, of 0.01. Purification of viral particles and preparation of viral antigen were performed as described previously (Mfihlberger et al., 1992) , and the final pellet of purified virus particles was resuspended in TNE (0.01 M-Tris-HC1 pH 7.4, 0.15M-NaC1, 2mM-EDTA) containing 1% SDS. When viral proteins were to be labelled, 20 laCi/ml [35S]methionine or [32P]orthophosphate (Amersham) was added 5 days post-infection (p.i.), and labelled virus was harvested 24 h thereafter. For viral genomlc RNA isolation, a protocol described in detail by Miihlberger et al. (1992) was used.
SFVL cells were infected with AcMNPV or recombinant AcMNPV (BVNP) at an m.o.i, of 1. Virus growth (27 °C) and purification were carried out as described elsewhere (Kuroda et al., 1986) . For 01 vivo labelling experiments, SFVL cells were infected at an m.o.i, of 10. Forty-eight hours p.l., infected cells were starved with the appropriate nutrient-deficient medium for 2h, labelled for 2h by adding 100 gCi/ml [35S]methionine or [32P]orthophosphate, and then lysed in RIPA buffer (20 mM-MES, 55 mM-Tris HC1, 200 mM-NaCk 10 mM-EDTA, 1% w/v SDS pH 7"8, 1% v/v Triton X-100, 5 % v/v Trasylol, 1 mM-PMSF, 10 mM-iodoacetamide). Insoluble components were pelleted at 14000 r.p.m, for 10 min in an Eppendorf centrifuge and the supernatant was stored at 4 °C.
E6 cells were infected with vaccinia virus (strain WR) or recombinant vaccinia virus (vSCNP) at an m.o.i, of 0.01. Preparation of virus stocks was performed as described by Mackett et al. (1986) . For in vivo labelling experiments E6 cells were infected at an m.o.i, of 10. Twentyfour hours p 1., cells were starved with the appropriate nutrientdeficient medium for 1 h, labelled for 2 h by adding 100 ~tCa/ml [35S]methionine or [*2P]orthophosphate, washed twice with PBS and lysed in RIPA buffer as described above.
Molecular cloning.
The NP open reading frame (ORF) was synthesized from vRNA as described previously using the following two sets of NP-specific oligonucleotides: (i) a primer set with a KpnI site (underhned), 5' CAGGGTACCGTGT-ATCATATAAATAAAGAAGAATATTAAC 3' (mRNA sense, bases 31 to 61), and 5' CAGGGTACCGCTGCATGTATGATGAGTCCC-ACATTGTGA 3' (vRNA sense, bases 2967 to 2939) and (ii) a primer set with a SalI site (underlined), 5' CAGGTCGACGAAGATATGG-ATTTACACAGTTTGTTGGA 3' (mRNA, bases 98 to 126) and 5' CAGGTCGACGACCACCATAGTATGCCCAGTCCTTGCCCG 3' (vRNA sense, bases 2375 to 2347). The numbering is according to the genome position (for reference see EMBL Data Library, emnew: MVREPCYC; accession number Z12132). The fragment obtained by using the primer set with KpnI sites was ligated into the KpnI site of the plasmid vector pAcYM1B (Matsuura et al., 1987) . The fragment obtained by using the primer set with Sall sites was ligated into the plasmid vectors pUEX (Bressan & Stanley, 1987) and pSCll (Chakrabarti et al., 1985) . For cloning into pSC11, the plasmid vector was altered by introducing a SalI linker into the unique Sinai site of the plasmid (Fig. 1) . Following cloning, the entire NP ORF was sequenced in all recombinant plasmids (pUEX NP, pAcYM1B NP and pSC NP) using the chain-terminating inhibitor method (Sanger et al., 1977) .
Expression of NP in Escherichia coll and production of polyclonal anti-NP sera. E. coli cells were transformed with pUEX-NP. Bacteria were grown at 30 °C and recombinant clones were selected by their ampicillin resistance. For expression studies, bacteria were grown for 5h at 30°C in 2YT medium containing 100gg/ml ampicillin. Expression of the fl-galactosldase NP fusion protein (fl-ga~NP) was induced by shifting the temperature to 42 °C for 2 h. Bacteria were pelleted at 3000 r.p.m, for 10 rain at 4 °C, washed once m TNE, and resuspended in a reducing lysis buffer (10% v/v glycerol, 0"I87M-Trx~HC1 pH 8.8, 3 % w/v SDS, 5 % v/v 2-mercaptoethanol, 0.05 % w/v bromophenol blue). Proteins were subjected to SDS-PAGE (Laemmli, 1970) , and the gel was stained with 0.3 M-CuClz. The fl-gagNP fusion protein band was cut out and incubated in a buffer containing 250 mM-Tns-HCI pH 8.0, 1 mM EDTA for 30 min (buffer was changed three times) followed by PBS. The sample was lyophilized, ground to powder, and resuspended in PBS. The suspension was used to immunize guinea-pigs. Immunization was performed with a 1:1 (v/v) mixture of antigen and Freund's complete adjuvant (Behring). Animals were boosted six times with a 1 : 1 (v/v) mixture of antigen and Freund's incomplete adjuvant (Behring). Screening for antibody production was done by immunoblotting and indirect immunofluorescence assays.
Transfection of SFVL cells and selection of recombinant AcMNPV (BVNP).
Transfection of SFVL cells (2.8 x 106 cells in a six-well tissue culture plate) was performed using the lipofectin precipitation technique (Feigner et al., 1987) as described by the manufacturer (Gibco BRL) with 1 lag AcMNPV wild-type DNA (Baculo Gold, Dianova) and 2 lag pAcYM1B NP DNA. Five days post-transfection the virus tltres of the supernatant fluids were determined by plaque assay as described elsewhere (Kretzschmar et al., 1992) . Screening for recombinant viruses was done by dot-blot hybridization according to the method of Pen et al. (1989) using a digoxigenin-labelled NP-specific probe (digoxigenin luminescent detection kit; Boehringer Mannbeim). For this, 3 x 10 a SFVL cells cultured in 96-well tissue culture plates were infected with 20 p.f.u, of virus. The supernatant fluids of positive wells were used in plaque assays in order to obtain purified recombinant BVNP (Kretzschmar et aL, •992) .
Construction of recombinant vaccinia virus (vSCNP).
Construction of pSC-NP was performed according to the method described by Chakrabarti et al. (1985) . For selection of recombinant virus the human cell line TK-143 was used (Rhim et al., 1975) . Briefly, 1.5 x 10 ° TK-143 cells were infected with vaccinia virus (WR strain) at an m.o.i. of 0.01. Cells were transfected (2 h p.i.) with 2.5 lag pSC-NP DNA by the lipofectin precipitation method (Feigner et aL, 1987) , and 24 h posttransfection the medium was replaced with Dulbecco's medium containing 10% fetal calf serum (FCS). Forty-eight hours posttransfection cells were scraped into the medium, pelleted, resuspended in 0.5 ml Dulbecco's medium without FCS, and lysed by three cycles of freezing and thawing. This suspension was used for plaque screening on TK 143 cellsinthe presence of 25 lag/ml bromodeoxyuridine (Mackett et al., 1986) . The plasmid vector pSCI 1 is constructed to express two foreign proteins, fl-galactosidase under the control of the vaccinia virus 11K promoter and an additional foreign gene (NP) under the control of the 7.5K promoter (Chakrabarti et al., 1985) . Recombinant viruses (vSCNP), generated by homologous recombination, were plaquepurified three times on TK 143 cells using selection for fl-galactosidasepositive plaques. Forty-eight hours p.i., plaque medium containing 300 lag/ml X-Gal was added, and screening for TK /fl-galactosidase + plaques was done 6 to 8 h later. Positive plaques (recognized by their blue colour) were further plaque-purified three times.
Dephosphoo'lation. Dephosphorylation of the NP was performed according to the method of Pr6haud et al. (1990) . Following in vivo labelling with [32p]orthophosphate or [~SS]methionine, infected cells were lysed in a buffer containing 0.5 % NP40, 20 mM-Tris-HC1 and 150 mM-NaC1 pH 8. One part of the cell lysate was dephosphorylated using 0.1 U/lal calf intestinal alkaline phosphatase (CIP) (Boehringer Mannheim) for 30 min at 37 °C. Controls were treated in the same way except that the CIP was omitted. After dephosphorylation, cell lysates were immunopreclpitated as described elsewhere (Huber et al., 1991) using an anti-fl-gal-NP guinea-pig serum (dilution 1 : 100) or antl-MBG guinea-pig serum (dilution 1:100) as indicated in the corresponding figures.
Immtmoblot analyses. Viral proteins were separated on 10% SDS polyacrylamide gels as described by Laemmli (1970) . After electrophoresis proteins were blotted onto PVDF membranes (Millipore) by the semi-dry blot technique. Immunodetection was performed using either the polyclonal anti-fl-gal-NP serum (1:300) or an anti-MBG serum raised in guinea-pigs, and a rabbit anti-guinea-pig secondary antibody coupled to horseradish peroxidase (1 : 500).
bldirect #nmunofluorescence tests. SFVL cells and E6 cells were cultured on glass coverslips and infected with AcMNPV or BVNP at an m.o.i, of 10 and vaccmia virus (WR) or vSCNP at an m.o.i, of 5 or 10, respectively. For SFVL, cells were rinsed with PBS 48 h p.l., fixed with 3 % paraformaldehyde for 30 rain. and the plasma membranes were lysed for 30 rain in 2% Triton X-100 in PBS (containing calcium and magnesium). E6 cells were rinsed with PBS and fixed with cold acetone (-20 °C) for 10 min. After fixation, cells were incubated for 1 h at room temperature with different primary antibodies. For vSCNPinfected E6 cells this was an anti-MBG guinea-pig serum, diluted 1:40 m PBS, and for BVNP-infected SFVL cells an anti-fl-gal-NP guineapig serum, diluted 1 : 40 in PBS. Subsequently, cells were washed three times with PBS and incubated with a fluorescein isothiocyanateconjugated rabbit anti-guinea-pig antiserum (Dako) diluted 1:50 in PBS, for 1 h at room temperature. Finally the cells were washed three times with PBS and examined using a fluorescence microscope (Zeiss, Axlomat).
Results

PCR amplification and cloning of the entire NP ORF
The entire ORF of the NP gene of MBG strain Musoke was synthesized from genomic RNA (vRNA) by RNA PCR using two sets of specific oligonucleotides (Fig. 1) plasmid vector pSC11 under the control o f the e a r l y / l a t e 7.5K promoter. Sequence analysis of the r e c o m b i n a n t plasmids revealed no deletions, insertions or point m u t a t i o n s in the cloned fragments, and confirmed the correct orientation in the a p p r o p r i a t e vectors (data not shown).
Expression o f recombinant N P
Expression from the p U E X plasmid is controlled by the ei857 repressor gene, whose temperature-sensitive protein p r o d u c t shuts off the Pr promoter. Expression is achieved by transferring the host cells from the n o r m a l growth temperature (30 °C) to 42 °C. In this system, the N P was expressed as an insoluble fusion protein in which the fusion point was close to the C terminus o f the fl-galactosidase. The fusion protein h a d a predicted Mr of a p p r o x i m a t e l y 200K and migrated on S D Sp o l y a c r y l a m i d e gels as expected. In i m m u n o b l o t analysis, the fusion protein reacted specifically with an a n t i -M B G guinea-pig serum d e m o n s t r a t i n g that the N P O R F was expressed as a part of the fusion p r o d u c t (Fig. 2 a) . The fusion p r o d u c t f l -g a l -N P was easily separated by S D S -P A G E from other E. coli proteins owing to its high M r. boosts the sera reacted positively in immunoblot analyses to the mature viral N P as well as to recombinant N P with titres of 1/1000 to 1/2000. These polyclonal anti-flg a l -N P sera were used at dilutions o f 1:40 in indirect immunofluorescence tests, 1 : 100 in immunoprecipitation assays and 1:300 in immunoblot analyses. Expression o f the N P O R F in both mammalian cells (E6), by recombinant vaccinia virus (vSCNP), and insect cells (SFVL), by recombinant baculovirus (BVNP), resulted in a protein product o f the expected M r (Kiley et al., 1988; migrating in SDS P A G E as a 94K protein and comigrating with the mature viral NP. Immunoblots with lysates of BVNP-infected S F V L and vSCNP-infected E6 ceils using the monospecific anti-fl-gal-NP sera confirmed the expression o f M B G N P in both systems (Fig. 2 b and c) . Additional protein bands of lower Mr, which also reacted with the sera used for immunoblot analyses represent degradation products o f the N P and were also c o m m o n l y seen in preparations of M B G structural proteins (Fig. 2a and b, lanes 3) . BVNP-infected S F V L cells expressed high levels of recombinant N P constituting approximately 10 % o f the total cellular protein mass. The protein could be visualized by Coomassie blue staining as shown in Fig.  5 (b). In contrast, the level of N P expression in E6 cells did not allow detection by Coomassie blue staining.
The expression o f recombinant N P could also be shown by in vivo labelling experiments in both eukaryotic systems using [35S]methionine (Fig. 3a and b and Fig.  5a ). In both expression systems (vaccinia virus and baculovirus) the recombinant N P appeared as a double band in S D S -P A G E . The lower mobility band had an apparent M r o f 94K and comigrated with the in vivo [35S]methionine-labelled mature viral N P (Fig. 3 a, b and Fig. 5a ). The second band had a slightly increased mobility on S D S -P A G E , migrated with an M r of approximately 92K and was not present in viral particles (Fig. 3 a, b and Fig. 5 a) . These two forms were separated only when the a m o u n t o f the protein loaded was low and could be also detected by Coomassie blue staining in the case o f BVNP-infected SFVL cells (Fig. 5b) . Both proteins reacted with the polyclonal anti-fl-gal-NP sera. Infection of E6 cells with v S C N P resulted in coexpression of fl-galactosidase due to the expression vector used for generating the recombinant virus (Fig. 3 a, lane 3 , marked by asterisk).
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Phosphorylation of the NP
Propagation of M B G in E6 cells in the presence o f [32P]orthophosphate revealed two phosphorylated virus structural proteins (Fig. 4a) . The major phosphorylated protein comigrated with the ssS-labelled viral NP. The second, weakly phosphorylated, protein had an apparent Mr of 30K to 35K and could be either VP35 or VP30. This finding is in line with the observation made for EBO which demonstrated phosphorylation o f N P and VP30 (Elliott et al., 1985) . In vivo labelling experiments with vSCNP-infected E6 cells and BVNP-infected S F V L cells using [32P]orthophosphate confirmed the phosphorylation o f the NP. In contrast to the double band that was detected by [~SS]methionine labelling, a single labelled protein was immunoprecipitated which comigrated with the mature in vivo 32P-labelled virion N P ( Fig. 4b and c) .
CIP treatment of the immunoprecipitated [32p]orthophosphate-labelled proteins revealed loss of the label (Fig. 4c ) whereas immunoblot analysis proved that the protein was not degraded by the treatment (data not shown).
Two different forms of N P
The two forms o f the NP, which were found in cells expressing the recombinant NP, could also be detected in MBG-infected E6 cells by in vivo [~S]methionine labelling (Fig. 5 c, lane 2) . In order to investigate the nature of these two forms, BVNP-infected insect cells were labelled with [35S]methionine and the proteins were then dephosphorylated with CIP. Phosphatase treatment resulted in the loss of the 94K form o f N P (Fig. 5 a, lanes 4 and 5, see arrows) and an increase in the intensity of the 92K form. Fig. 5(b) shows a Coomassie blue-stained S D Spolyacrylamide gel of BVNP-infected S F V L cell lysates treated in the same manner as described for Fig. 5 (a) and again it can be seen that the 94K form was converted into the 92K form. The heavily stained protein in lane 4 with an Mr of 69K represents the CIP. These data demonstrated that the N P exists in two forms, a phosphorylated 94K form and an unphosphorylated 92K form. However, in virion particles (Fig. 5a and b, lanes 3 ) the N P is present only in the phosphorylated (94K) form.
Intracellular distribution of the recombinant NP
Indirect immunofluorescence assays using an anti-MBG guinea-pig serum (E6 cells) or the anti-fl-gal-NP serum (insect cells) were performed to determine the intracellular distribution o f the N P expressed in mammalian and insect cells. Both recombinant NPs were exclusively localized in the cytoplasm of the infected cells, vSCNPinfected E6 cells showed large, primarily perinuclear, cytoplasmic inclusion bodies ( Fig. 6a to d ) whereas SFVL cells infected with BVNP showed a uniform distribution of the NP in the cytoplasm (Fig. 6 e and f) .
Discussion
Sequence analysis of the genes encoding filovirus NPs and comparison with the sequences of other NNS RNA virus nucleoproteins suggests that filovirus NP seems to be the functional analogue of the nucleoproteins of paramyxoviruses and rhabdoviruses . This is further supported by the fact that filoviral NP genes are located at the extreme 3' end of the viral genome as found with all NNS RNA virus nucleoprotein genes . As shown for all nucleoproteins, filoviral NPs are the major components of the viral ribonucleoprotein complex and are tightly bound within the complexes. However, in comparison to all other NNS RNA viruses, filoviral NPs have unusually high MrS. Whereas the nucleoproteins of paramyxoviruses range from 42K to 62K (Morgan, 1991) and those of rhabdoviruses from 47K to 62K (Nichol, 1993) , the NP of M B G has an M r of 94K and that of EBO an M r of 104K (Elliott et al., 1985) . This fact suggests that filoviral NPs may have an additional function compared with the nucleoproteins of paramyxoviruses and rhabdoviruses and this function may be located in the Cterminal part of the NP. In order to characterize filovirus NPs better and to define their functional role we expressed the M B G (strain Musoke) NP in different cell systems. The vaccinia virus system was chosen because of its ability to infect Vero cells, a mammalian cell line that is commonly used for the propagation of all filoviruses and thus reflects more authentic conditions. The baculovirus system was chosen for expression of the protein in insect cells (SFVL cell line); this is known to provide large amounts of expressed foreign proteins (Luckow & Summers, 1988) . The recombinant proteins were examined for their cellular localization and co-and post-translational modifications. In addition, the M B G NP was expressed as a Cterminal fl-galactosidase fusion protein in E. coli for production of specific anti-NP sera as tools for diagnosis and research.
Expression of the MBG NP in both cell lines revealed a product of the expected M r that comigrated on SDS PAGE with the mature viral NP (Fig. 2 to 5 ). As expected, NP was expressed to higher levels in insect cells infected with the recombinant baculovirus (BVNP) (Fig.  5b) than in E6 cells infected with the recombinant vaccinia virus (vSCNP). Expression of NP by vSCNP could only be shown by immunoblot analysis or in vivo labelling ( Fig. 2b and 3a) . This phenomenon may be due in part to the fact that the NP ORF contains a vaccinia virus early transcription termination signal (3" T T T T T A T 5'; Rohrmann et al., 1986) 393 nucleotides downstream of the A U G initiation codon .
In vivo labelling of virion particles using [32P]orthophosphate in combination with CIP treatment has clearly demonstrated that the mature M B G NP is phosphorylated (Fig. 4) . Phosphorylation is not a unique feature of filoviral NPs. Among NNS RNA viruses the nucleoproteins of rabies virus (Sokol & Clark, 1973) , Sendai virus (Lamb & Choppin, 1977) and measles virus (Norrby & Oxman, 1990) are phosphorylated.
Phosphorylation of NP was also demonstrated in both expression systems investigated (Fig. 4) . This indicates that phosphorylation of MBG NP could be mediated in part by cellular kinases. Acceptors for phosphorylation can be either serine, threonine or tyrosine residues depending on the particular protein kinase (for review see Leader & Katan, 1988) . These amino acid residues are found throughout the MBG NP. Previous studies have shown that different phosphorylated residues on a single protein result from the action of different protein kinases. This was shown for glycogen synthetase (Cohen, 1985) and the phosphorylation of the P protein of vesicular stomatitis virus which is carried out by both cellular kinases and the kinase activities of the viral L protein (Banerjee & Barik, 1992 (1990) have demonstrated a kinase activity of the L protein by in vitro phosphorylation of NP and P protein. In the case of the recombinant MBG NP one should also consider the possibility of kinase activities related to an infection with baculovirus or vaccinia virus. Therefore our studies do not necessarily allow the conclusion that phosphorylation of recombinant NP is due to the same enzymatic activities and the use of identical acceptors for phosphorylation as in MBG-infected cells.
Expression of the NP ORF in both systems as well as in the MBG-infected E6 cells revealed the synthesis of a larger phosphorylated and a smaller unphosphorylated form of the protein (difference in M r approx. 2K). However, in virion particles only the phosphorylated (94K) form could be detected (Fig. 3 to 5) . A similar phenomenon was observed when recombinant simian virus 40 large T antigen was expressed in human 293 cells. Expression resulted in two forms of the large T antigen differing in M r by 1K which was due to a conformational change related to phosphorylation of threonine residues (Gr~isser & K6nig, 1992) . On the other hand, the lower M r form could also be the result of a proteolytic process as shown for the major nucleocapsid protein of influenza virus. This appears, depending on the cell type, at late stages of the infection cycle in two differently migrating forms (Zhirnov & Bukrinskaya, 1981) . NPsa (53K) was shown to be the proteolytically cleaved form of NP~ (56K). However, the fact that [32P]orthophosphate labelling of the NP showed only the larger form to be phosphorylated and the conversion of the 94K form into the 92K form by phosphatase treatment do not support proteolytic degradation.
Indirect immunofluorescence studies demonstrated that recombinant NP is found exclusively in the cytoplasm of infected cells (Fig. 6) . The immunostaining pattern which can be seen in these cells is similar to the pattern found in MBG-infected Vero cells and human endothelial cells (Becket et al., 1992; Schnittler et al., 1993) . In MBG-infected cells this pattern is related to the formation of intracytoplasmic inclusion bodies which consist of viral nucleocapsids. Since viral nucleocapsids are composed of genomic RNA, NP and probably three additional viral proteins (VP35, VP30 and L) (Elliott et al., 1985; Kiley et al., 1988) , our findings indicate that nucleocapsid-like structures can also be formed by spontaneous aggregation of NP molecules. Furthermore, NP molecules could also aggregate with cellular RNAs and/or proteins resulting in formation of nucleocapsidlike structures. Formation of spontaneous aggregates was also found in cells expressing recombinant nucleocapsid protein of vesicular stomatitis virus (Sprague et al., 1983) or measles virus nucleoprotein (Spehner et al., 1991) .
The exact function of phosphorylation of the nucleoproteins of NNS RNA viruses has not yet been elucidated. It is noteworthy that only the phosphorylated form of the NP is found in virion particles of MBG. This result may indicate that only the phosphorylated NP is able to interact with genomic RNA and form the nucleocapsid complex. It is known for several proteins that phosphorylation is a prerequisite for binding to RNA. The rex protein of human T lymphotropic virus type II loses its affinity for the R region of the 5" long terminal repeat after treatment with phosphatases (Green et al., 1992) . Han et al. (1992) showed that phosphorylation determines the interaction between the trans-activation response (TAR) region of human immunodeficiency virus type 1 and a cellular TAR RNA stem-binding factor. In this context phosphorylation of the NP should be considered in relation to the role of this protein during the transcription and replication of MBG.
